Ameriprise
ASMB icon

Ameriprise’s Assembly Biosciences ASMB Stock Holding History

Ameriprise’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-845
Closed -$21K – 3958
2022
Q2 		$21K Hold
845
– – ﹤0.01% 3853
2022
Q1 		$21K Sell
845
-170
-17% -$3.65K ﹤0.01% 3902
2021
Q4 		$28K Sell
1,015
-204
-17% -$6.69K ﹤0.01% 3920
2021
Q3 		$51K Sell
1,219
-100
-8% -$4.19K ﹤0.01% 3816
2021
Q2 		$61K Sell
1,319
-94
-7% -$4.66K ﹤0.01% 3850
2021
Q1 		$78K Buy
1,413
+474
+50% +$31.4K ﹤0.01% 3789
2020
Q4 		$69K Buy
+939
New +$110K ﹤0.01% 3708

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ameriprise's ASMB Position: Q3 2022 in Review

Ameriprise sold out of Assembly Biosciences (ASMB) in Q3 2022, closing a stake of 845 shares — an estimated $21K sold.

Ameriprise first reported a position in ASMB in Q4 2020 and held it in 7 quarters. The position peaked at $78K in Q1 2021. 50 funds tracked by Wall St. Rank hold ASMB as of Q3 2022.

  • Ameriprise reported no remaining Assembly Biosciences position as of Q3 2022 after selling out during the quarter.
  • Ameriprise sold 845 Assembly Biosciences shares in Q3 2022, an estimated $21K.
  • Ameriprise first reported a position in Assembly Biosciences in Q4 2020 and held it in 7 quarters.
  • Ameriprise's Assembly Biosciences position peaked at $78K in Q1 2021.
  • 50 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.